The mechanisms mediating the complex insulin secretory dynamics have both fundamental and clinical significance, as the first-phase is absent (or attenuated) in IVGTT’s performed on patients with Type 2 diabetes mellitus (5–7). Here, INS is linked to type 2 diabetes mellitus.